How Early-stage VCs are Adjusting in a Bear Market

BioCentury spoke with Sofinnova, Novo Holdings, INKEF Capital, M Ventures and Healthcap at this years Anglonordic Life Science Conference about how early-stage VCs are adjusting in a bear market.

As part of a panel session, hosted by Stephen Hansen, at the conference on 5 May, Optimum’s clients explored the latest dynamics of syndicate building for early-stage VCs. With more emphasis being put on demonstrating longer-term stamina, young companies are having to set up investment syndicates with investors that can get them through multiple rounds.

Those companies who are not able to build such a strong syndicate with investors will need to be agile and have alternative options available at their disposal.

Read more in BioCentury’s latest piece.

By Optimum

For more information about Optimum Strategic Communications, please get in touch

We'd love to hear from you...

GET IN TOUCH